Trials / Completed
CompletedNCT00447551
Canadian Aesthetic Experience With Sculptra Therapy
Canadian Study of the Use of Injectable POLY-L-LACTIC Acid (Sculptra Therapy) in Aesthetic Medicine
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 76 (actual)
- Sponsor
- Bausch Health Americas, Inc. · Industry
- Sex
- All
- Age
- 18 Years – 75 Years
- Healthy volunteers
- Not accepted
Summary
Primary objective To evaluate the degree of correction achievable with Sculptra for nasolabial folds, mid- and lower facial volume loss, jawline laxity and other signs of facial ageing. To document the types and incidence of device-related adverse events with Sculptra.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Poly-L-Lactic Acid | Deep dermal injection |
Timeline
- Start date
- 2007-01-01
- Primary completion
- 2008-04-01
- Completion
- 2008-04-01
- First posted
- 2007-03-14
- Last updated
- 2019-11-19
Locations
1 site across 1 country: Canada
Source: ClinicalTrials.gov record NCT00447551. Inclusion in this directory is not an endorsement.